4//SEC Filing
BROWN MICHAEL S 4
Accession 0001968202-23-000009
CIK 0000872589other
Filed
Apr 23, 8:00 PM ET
Accepted
Apr 24, 4:05 PM ET
Size
10.0 KB
Accession
0001968202-23-000009
Insider Transaction Report
Form 4
BROWN MICHAEL S
Director
Transactions
- Exercise/Conversion
Common Stock
2023-04-21$520.01/sh+3,070$1,596,431→ 4,317 total - Sale
Common Stock
2023-04-21$798.42/sh−3,070$2,451,149→ 1,247 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2023-04-21−3,070→ 0 totalExercise: $520.01Exp: 2026-01-04→ Common Stock (3,070 underlying)
Holdings
- 5,000(indirect: by SLAT)
Common Stock
- 6,162(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 22, 2023.
- [F2]These shares are held in a trust for the benefit of the reporting person's immediate family members. The reporting person's spouse is trustee of the trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- [F3]The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.
Documents
Issuer
REGENERON PHARMACEUTICALS, INC.
CIK 0000872589
Entity typeother
Related Parties
1- filerCIK 0001174475
Filing Metadata
- Form type
- 4
- Filed
- Apr 23, 8:00 PM ET
- Accepted
- Apr 24, 4:05 PM ET
- Size
- 10.0 KB